OALib Journal期刊
IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML
DOI: 10.1080/2162402X.2018.1477460
Abul B. M. M. K. Islam ,
Alvaro Urbano-Ispizua ,
Belen Lopez-Millan ,
Clara Bueno ,
Cristina Prieto ,
Damia Romero-Moya ,
Eduardo Anguita ,
Fernando Anjos-Afonso ,
Francisco Gutierrez-Agüera ,
Heleia Roca-Ho ,
Jose Antonio Bejarano-Garcia ,
Jose Antonio Perez-Simon ,
Jose Luis Fuster ,
Mar Iglesias ,
Montse Rovira ,
Pablo Menendez ,
Paula Costales ,
Pedro Marín ,
Rafael Diaz de la Guardia ,
Silvia Menendez Keywords: AML , BM-MSC , IMiDs , lenalidomide , pomalidomide , AraC , Idarubicin , xenografts
Abstract:
Full-Text
Contact Us
service@oalib.com
QQ:3279437679
WhatsApp +8615387084133
